The Oxford/AstraZeneca potential COVID-19 vaccine's late-stage trial results are deemed as "intriguing." It will be further probed how an initial half-dose of the shot offers more protection.
Full ArticleOxford COVID-19 Vaccine Up to 90% Effective, Only Half-Dose Needed
HNGN
0 shares
1 views
You might like
Related news coverage
Moderna boss says its COVID-19 vaccine should be given to vulnerable
Proactive Investors
Moderna Inc (NASDAQ:MRNA) has confirmed its COVID-19 vaccine achieved a 94% success in its recent phase III trial and that it will..
-
Thailand signs supply deals for AstraZeneca COVID-19 vaccine
SeattlePI.com
-
AstraZeneca mulls new coronavirus vaccine trial following results confusion
Proactive Investors
-
Oxford/AstraZeneca Covid vaccine 'dose error' explained
BBC News
-
AstraZeneca manufacturing error clouds Oxford vaccine study results
Mid-Day
Advertisement
More coverage
AstraZeneca Admits To Mistakes In Coronavirus Vaccine Trial
Newsy
Watch VideoScientists and industry experts are now questioning the effectiveness of AstraZeneca's experimental covid-19 vaccine..
-
UK asks regulator to assess AZ-Oxford vaccine amid questions
SeattlePI.com
-
India to consider clinical trials data of two full doses of AstraZeneca vaccine
IndiaTimes
-
AstraZeneca says it will likely do another study of COVID-19 vaccine after accidental lower dose shows higher efficacy
TechCrunch
-
Oxford’s 90% vaccine finding was ‘only in younger age groups’
Belfast Telegraph